The study reports improvements in glycemic control, GLP-1 response and lipid markers with bio-optimised berberine.... Aug 14
Stempeutics Research, a group company of Manipal Education and Medical Group, today announced that the United States Patent and Trademark Office (USPTO) has granted U.... Aug 13
Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline ... Apr 04
In a world searching for ways to protect cognitive health, the answer may sometimes arrive through the most unexpected path i.e. a gentle scent ... Mar 26
The idea that adjusting the angle of the foot could ease pain and slow cartilage damage suggests that the mechanics of everyday motion may hold ... Mar 26
... Mar 23
Peer-reviewed results published in Osteoarthritis and Cartilage Open show significant improvements in pain, function, and structural outcomes versus placebo.... Jan 20
For a condition that steals breath, rest, and years of healthy life, the possibility of relief in the form of a simple tablet feels almost ... Jan 17
If this vaccine continues to prove effective in later trials, it could one day stand as a testament to what proactive science can achieve against ... Dec 27
These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 ... Oct 31
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 16
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 15
Everest Medicines today announced that the results of its Asian multicenter Phase III ENLIGHT UC study of etrasimod for the treatment of subjects with moderately ... Oct 10
HighTide Therapeutics, Inc. (2511.HK) is an innovative biopharmaceutical company specializing in metabolic diseases.... Sep 17
This is a reminder that science continues to work tirelessly, that hope is not lost, and that even against the most silent of killers, humanity ... Sep 05
Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) ... Aug 28
... Aug 16
Everest Medicines recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R).... Aug 12
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ... Aug 01
As science continues to discover new links, one thing becomes increasingly clear that the smartest workout plan isn’t just about lifting more or running ... Jun 20
Once dismissed as relics of medieval medicine, therapies like bloodletting, leeching, and cupping are making a strange comeback. Are they healing tools reborn—or just ... Jun 10
In India, discussing mental health or birth control remains taboo. Many women blame themselves for feeling off, unaware their contraception could be the culprit.... May 14
Everest Medicines announced that the supplemental New Drug Application (sNDA) for NEFECON has received full approval from the China National Medical Products Administration (NMPA).... May 08
HighTide Therapeutics, a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases.... Apr 25
... Apr 15
-Advertisements-
.jpeg)
Saturday, October 10, 2026
.jpg)
.jpg)
.jpeg)
.jpeg)
.png)
.png){kind=logo}
.jpeg)
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)